Pharmaceutical pricing consulting, built on our own data
When a launch, an HTA submission or a policy change puts a date on your pricing decision, you need an answer you can defend. Our senior pricing and market access consultants start every project from GPI’s own pricing, reimbursement and HTA data, and work with pharmaceutical and biotech teams from early pipeline to post-launch.

- Senior pharmaceutical expertise
- Data-driven strategic framework
- Flexible partnership model
Is a pricing or market access deadline coming up?
Most of our projects start with a date in the diary. If one of these sounds familiar, we should talk.
A launch is 12 to 18 months away and there is no agreed price corridor or launch sequence.
An HTA submission or PICO scoping is coming up.
Loss of exclusivity is approaching and you need a pricing response across several markets.
A policy shift, such as MFN effects travelling through international reference pricing, or changes to how the NHS commissions and contracts locally.
Procurement has issued an RFP for pricing research and needs a specialist bid.
Our pharmaceutical pricing consulting projects
Launch pricing strategy
Price corridors, IRP and MFN scenario modelling and launch sequencing, showing where to launch first and how each market affects your price.
Primary pricing research
Willingness-to-pay and price sensitivity research with payers and HCPs, using conjoint, price-elasticity or IDI-based designs, light-touch or comprehensive.
Market access and payer strategy
Payer IDIs, HTA and PICO strategic assessments, and UK local contracting strategy, built around the evidence payers will look for.
Rapid pricing assessment
Analogue-based benchmarking for an early price range on an asset or opportunity, for pipeline reviews and BD&L decisions, in 2 to 4 weeks.
Expert, pharmaceutical strategic consulting tailored to your needs
GPI Consulting and GPI Horizon
GPI Horizon gives an evidence-backed starting point for pricing an early-stage asset. Teams compare several TPP scenarios in one place, with evidence set against analogues across 20 to 30+ payer-validated clinical and commercial criteria. It is designed to sit alongside other research.
When a GPI Horizon result raises a strategic question, such as how to sequence a launch or what a TPP scenario means for the price corridor, our consultants take it further using the same data. A rapid pricing assessment uses the same analogue approach and takes 2 to 4 weeks.
How a GPI Consulting project runs
Our systematic consulting approach ensures comprehensive analysis and actionable recommendations for your most complex pharmaceutical pricing and market access challenges.
Introductory call
A brief call to understand the decision, the deadline and the markets in scope.
Scoping
We propose a scope, with a light-touch or comprehensive option where it fits, and agree it with you.
Analysis
The work starts from GPI’s own data, with primary research or payer input where the project needs it.
Delivery
We deliver within the agreed timeline, with recommendations and the evidence behind them.
Who we work with
Our pharmaceutical pricing consulting clients range from specialty pharma start-ups launching their first product to mid-size and rare disease biotechs and the global and affiliate teams of large pharma companies. We also work with companies in vaccines, plasma-derived products, clinical nutrition and drug-device combinations.
We usually work with Heads of Pricing, Global Pricing and Market Access Directors, Market Access Leads, country affiliate teams, and BD&L and commercial strategy teams.
How GPI Consulting works
Every project starts from GPI’s pricing, reimbursement and HTA data: 200 million+ data points across 60+ pricing markets, 100+ IRP markets and 30+ HTA markets, with 95% data completeness across covered markets. You don’t need to buy data separately before the work begins.
Senior people lead the work
Senior pricing and market access consultants lead every engagement. In the words of one client, Pfizer, GPI is “always ready to listen, flexible, available, and amenable to all business needs”.
The scope fits the decision
Not every question needs a 14-week study. We scope each project to the decision in front of you. For a recent willingness-to-pay project, we offered a light-touch design and a comprehensive one, so the client could match the method to their budget.
No subscription needed
You can work with GPI Consulting without a GPI Pulse or GPI Horizon subscription. If you want to keep tracking prices, indications and HTA outcomes after a project, platform access is available.

Michelle Pardo
GPI is always ready to listen, flexible, available and amenable to all business needs. Pfizer relies heavily on GPI’s Cost of Treatment calculations in order to determine which products we have to report on, and therefore upholding our reputation.

Marc Gauthier-Darnis
Major impact. As GPI is our only price database provider, we fully trust them… We’ve been working together for a while and GPI has always met our expectations and solved our problems if any.
What our clients say
Let’s connect
Connect with our experts for a free consultation and tailored solutions.
Call us on +44 (0) 203 369 0039 or fill out our form, and we’ll contact you within one business day.
FAQs
What does a pharmaceutical pricing consulting project involve?
GPI Consulting provides pharmaceutical pricing consulting and market access strategy. Our four main projects are launch pricing strategy, primary pricing research, market access and payer strategy, and rapid pricing assessments. Every project starts from GPI’s own pricing, reimbursement and HTA data.
How long does a pharmaceutical pricing consulting project take?
It depends on the project. A rapid pricing assessment takes 2 to 4 weeks. Launch pricing strategy usually takes 8 to 10 weeks, market access and payer strategy 8 to 12 weeks, and primary pricing research 10 to 14 weeks, depending on fieldwork.
Do I need a GPI Pulse or GPI Horizon subscription to work with GPI Consulting?
No. You can work with GPI Consulting without a platform subscription. Clients who want to keep tracking prices, indications and HTA outcomes after a project can add platform access.
What data do GPI’s consultants use?
Our consultants work from GPI’s own published pricing, reimbursement and HTA data: 200 million+ data points across 60+ pricing markets, 100+ IRP markets and 30+ HTA markets. Our data covers published prices, not confidential net prices.
How does GPI Consulting work with GPI Horizon?
GPI Horizon gives an evidence-backed starting point for pricing an early-stage asset and lets teams compare TPP scenarios in one place. When that raises a strategic question, such as launch sequencing or what a scenario means for the price corridor, our consultants take it further using the same data.
Expert strategies, industry trends & real results
Germany’s 15.5% rebate on patented medicines takes effect on 1
Gene therapy JCA submissions face a distinct methodological test, and
Pre-launch price forecasting for rare disease assets was tested against
